We are investigating the potential of DPSCs in cell-based and cell-free applications for disease models, while studying the cellular and molecular mechanisms involved in tissue regeneration. Additionally, we are exploring the role of stem cell-derived secretory factors in controlling stem cell fate and promoting tissue regeneration. Our current focus is on using 3D culture techniques to gain deeper understanding of molecular mechanisms, genetic and epigenetic changes associated with tissue regeneration.

We are incorporating advanced techniques such as next-gen sequencing, RNA sequencing, and chip sequencing to unravel regulatory domains governing various cellular processes. Using explant methods to isolate DPSC, a homogeneous stem cell population can be efficiently harvested, free from other cells like endothelial and pericytes. These cell types remain in the cell culture when DPSCs are established using enzymatic procedures.

Our research using DPSCs as a cellular model for drug screening and tissue regeneration can develop novel therapies, advanced personalized medicine, and have far-reaching implications in regenerative medicine including craniofacial reconstruction and in vivo bone regeneration after dental extraction. We are currently investigating how DPSCs can be used to address bone defects, such as long bone and calvarial defects. Additionally, we are exploring the potential therapeutic implications of secretory molecules derived from DPSCs in various disease models, including neurodegeneration and glaucoma.